ProductSubpage
About novartis Pharmaceutical Corporation
back to products index

Lamisil®

((terbinafine hydrochloride) tablets and oral granules

 

Product Images

Right-click link to download image.

Low Resolution

Lamisil 125mg granules packet (40KB)

Lamisil 125mg granules-58 (44KB)

Lamisil 125mg granules-59 (40KB)

Lamisil 187.5mg granules packet (40KB)

Lamisil 187.5mg granules-58 (44KB)

Lamisil 187.5mg granules-59 (44KB)

Lamisil 250mg tablet (28KB)

High Resolution

Lamisil 250mg tablet (552KB)

Lamisil 250mg bottle (460KB)

Lamisil granules 125mg package (472KB)

Lamisil granules 125mg package (308KB)

Lamisil granules 125mg package (464KB)

Lamisil granules 125mg package (364KB)

Lamisil granules 187.5mg package (476KB)

Lamisil granules 187.5mg package (312KB)

Lamisil granules 187.5mg package (384KB)

Lamisil granules 187.5mg package (348KB)

Prescribing Information

Prescribing Information contains useful information like a treatment's ingredients and the results of the clinical trials. Here, the prescribing information will show in a separate window in an easy to print format called PDF.

Download Lamisil tablets prescribing information

Download Lamisil oral granules prescribing information

Patient Assistance Foundation:

Lamisil Oral Granules Enrollment information

For HealthCare Professionals:

HCP Resources

Research & Development

Clinical Trials

www.quo.novartis.com

back to products index

PATIENT ASSISTANCE PROGRAMS

Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.

RESEARCH & DEVELOPMENT


We maintain the most promising pipeline in the industry to treat and help people around the world.

CLINICAL TRIALS


We are constantly conducting clinical trials to determine the safety and efficacy of new drugs and treatments. The success of these trials relies on patients who volunteer to participate.

NOVARTIS PHARMACEUTICALS NEWS

Read about the latest news and events from Novartis Pharmaceuticals Corporation.